Authors:
Meaume, S
Rudnichi, A
Lynch, A
Bussy, C
Sebban, C
Benetos, A
Safar, ME
Citation: S. Meaume et al., Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old, J HYPERTENS, 19(5), 2001, pp. 871-877
Authors:
Ray-Coquard, I
Ghesquiere, H
Bachelot, T
Borg, C
Biron, P
Sebban, C
LeCesne, A
Chauvin, F
Blay, JY
Citation: I. Ray-coquard et al., Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas, BR J CANC, 85(6), 2001, pp. 816-822
Authors:
Colombat, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Delwail, V
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoullas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Thieblemont, C
Montestruc, F
Mathieu-Boue, A
Benzohra, A
Solal-Celigny, P
Citation: P. Colombat et al., Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy forpatients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation, BLOOD, 97(1), 2001, pp. 101-106
Authors:
Fiere, D
Vernant, JP
Michallet, M
Degos, L
Leblond, V
Olteanu, N
Boucheix, C
Charrin, C
Varet, B
Huguet, FR
Delannoy, A
Gratecos, N
Lepage, E
Sebban, C
Citation: D. Fiere et al., Treatment of adult acute lymphoblastic leukemia long term results of a prospective study: LALA 87, HEMAT BLOOD, 40, 2001, pp. 389-392
Authors:
Voog, E
Sebban, C
Biron, P
Philip, T
Blay, JY
Citation: E. Voog et al., A prospective study of the LMB regimen for diffuse large cell non Hodgkin's lymphoma in adults, LEUK LYMPH, 36(5-6), 2000, pp. 525-532
Authors:
Blay, JY
Ongolo-Zogo, P
Sebban, C
Carrie, C
Thiesse, P
Biron, P
Citation: Jy. Blay et al., Primary cerebral lymphomas: Unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses, ANN ONCOL, 11, 2000, pp. 39-44
Authors:
Thiebaut, A
Vernant, JP
Degos, L
Huguet, FR
Reiffers, J
Sebban, C
Lepage, E
Thomas, X
Fiere, D
Citation: A. Thiebaut et al., Adult acute lymphocytic leukemia study testing chemotherapy and autologousand allogeneic transplantation - A follow-up report of the French protocolLALA 87, HEMAT ONCOL, 14(6), 2000, pp. 1353
Authors:
Tilly, H
Mounier, N
Lederlin, P
Briere, J
Dupriez, B
Sebban, C
Bosly, A
Biron, P
Nouvel, C
Herbrecht, R
Bordessoule, D
Coiffier, B
Citation: H. Tilly et al., Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study, J CL ONCOL, 18(6), 2000, pp. 1309-1315
Authors:
Haioun, C
Lepage, E
Gisselbrecht, C
Salles, G
Coiffier, B
Brice, P
Bosly, A
Morel, P
Nouvel, C
Tilly, H
Lederlin, P
Sebban, C
Briere, J
Gaulard, P
Reyes, F
Citation: C. Haioun et al., Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study, J CL ONCOL, 18(16), 2000, pp. 3025-3030
Authors:
Michallet, M
Philip, T
Philip, I
Godinot, H
Sebban, C
Salles, G
Thiebaut, A
Biron, P
Lopez, F
Mazars, P
Roubi, N
Leemhuis, T
Hanania, E
Reading, C
Fine, G
Atkinson, K
Juttner, C
Coiffier, B
Fiere, D
Archimbaud, E
Citation: M. Michallet et al., Transplantation with selected autologous peripheral blood CD34(+)Thy1(+) hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution, EXP HEMATOL, 28(7), 2000, pp. 858-870
Authors:
Ferme, C
Sebban, C
Hennequin, C
Divine, M
Lederlin, P
Gabarre, J
Ferrant, A
Caillot, D
Bordessoule, D
Brice, P
Moullet, I
Berger, F
Lepage, E
Citation: C. Ferme et al., Comparison of chemotherapy to radiotherapy as consolidation of complete orgood partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial, BLOOD, 95(7), 2000, pp. 2246-2252
Authors:
Mounier, N
Haioun, C
Cole, BF
Gisselbrecht, C
Sebban, C
Morel, P
Marit, G
Bouabdallah, R
Ravoet, C
Salles, G
Reyes, F
Lepage, E
Citation: N. Mounier et al., Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission, BLOOD, 95(12), 2000, pp. 3687-3692
Authors:
Ferme, C
Cosset, JM
Fervers, B
Sebban, C
Cutuli, B
Henry-Amar, M
Stines, J
Giammarile, F
Bey, P
Carella, AM
Philip, T
Citation: C. Ferme et al., Standards, options and recommendations for the management of patients withHodgkin's disease, PRESSE MED, 28(40), 1999, pp. 2233-2242
Authors:
Ray-Coquard, I
Le Cesne, A
Rubio, MT
Mermet, J
Maugard, C
Ravaud, A
Chevreau, C
Sebban, C
Bachelot, T
Biron, P
Blay, JY
Citation: I. Ray-coquard et al., Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens, J CL ONCOL, 17(9), 1999, pp. 2840-2846
Authors:
Sebban, C
Zhang, XQ
Tesolin-Decros, B
Millan, MJ
Spedding, M
Citation: C. Sebban et al., Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission, BR J PHARM, 128(5), 1999, pp. 1045-1054
Authors:
Sebban, C
Tesolin-Decros, B
Millan, MJ
Spedding, M
Citation: C. Sebban et al., Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil, BR J PHARM, 128(5), 1999, pp. 1055-1063